Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04455750
Title A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant To Testosterone-Deprivation Therapy (CASPAR)
Acronym CASPAR
Recruitment Active, not recruiting
Gender male
Phase Phase III
Variant Requirements No
Sponsors Alliance for Clinical Trials in Oncology
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.